Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6401
PUT
Cardiff Oncology
CRDF
$72.9M
| $1.14M | ﹤0.01% |
63,200
+6,900
| +12% | +$121K |
|
6402
Helix Energy Solutions
HLX
$1.53B
| $1.14M | ﹤0.01% |
270,495
-995,534
| -79% | -$3.33M |
|
|
DSPG
6403
DELISTED
DSP Group Inc
DSPG
| $1.14M | ﹤0.01% |
68,443
+34,309
| +101% | +$528K |
|
6404
Virtus Biotech ETF
BBP
$107M
| $1.13M | ﹤0.01% |
21,304
+13,481
| +172% | +$691K |
|
6405
CALL
Westlake Corp
WLK
$9.94B
| $1.13M | ﹤0.01% |
13,900
-25,200
| -64% | -$1.88M |
|
6406
PUT
Northwest Bancshares
NWBI
$2.3B
| $1.13M | ﹤0.01% |
88,900
+18,500
| +26% | +$211K |
|
|
LBAI
6407
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.13M | ﹤0.01% |
89,187
+13,125
| +17% | +$155K |
|
|
SYRS
6408
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.13M | ﹤0.01% |
+10,428
| New | +$952K |
|
|
AHRT
6409
PUT
AH Realty Trust
AHRT
$501M
| $1.13M | ﹤0.01% |
100,700
+48,600
| +93% | +$492K |
|
6410
PUT
Butterfly Network
BFLY
$2.39B
| $1.13M | ﹤0.01% |
+57,100
| New | +$731K |
|
6411
Fidelity Low Duration Bond Factor ETF
FLDR
$1.99B
| $1.13M | ﹤0.01% |
+22,137
| New | +$1.13M |
|
|
AZRE
6412
DELISTED
Azure Power Global Limited
AZRE
| $1.13M | ﹤0.01% |
+27,719
| New | +$880K |
|
6413
PUT
Voyager Therapeutics
VYGR
$199M
| $1.13M | ﹤0.01% |
+157,900
| New | +$1.52M |
|
|
ORAN
6414
DELISTED
Orange
ORAN
| $1.13M | ﹤0.01% |
95,177
-128,481
| -57% | -$1.5M |
|
6415
CALL
Amdocs
DOX
$6.08B
| $1.13M | ﹤0.01% |
15,900
-11,600
| -42% | -$728K |
|
6416
Cambria Foreign Shareholder Yield ETF
FYLD
$712M
| $1.13M | ﹤0.01% |
46,685
+9,369
| +25% | +$208K |
|
6417
iShares US Healthcare Providers ETF
IHF
$1.23B
| $1.13M | ﹤0.01% |
24,040
-180,770
| -88% | -$8.02M |
|
6418
CALL
Vertiv
VRT
$114B
| $1.13M | ﹤0.01% |
60,400
+44,700
| +285% | +$822K |
|
|
SHYF
6419
CALL
DELISTED
The Shyft Group
SHYF
| $1.13M | ﹤0.01% |
39,700
-31,200
| -44% | -$748K |
|
6420
CALL
DigitalBridge
DBRG
$2.94B
| $1.13M | ﹤0.01% |
58,450
+26,350
| +82% | +$422K |
|
6421
Fair Isaac
FICO
$23.3B
| $1.13M | ﹤0.01% |
2,201
-11,389
| -84% | -$5.3M |
|
|
BRMK
6422
CALL
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $1.13M | ﹤0.01% |
110,300
-76,000
| -41% | -$774K |
|
|
ALX
6423
Alexander's
ALX
$1.34B
| $1.12M | ﹤0.01% |
4,054
-2,938
| -42% | -$778K |
|
6424
VanEck Natural Resources ETF
HAP
$311M
| $1.12M | ﹤0.01% |
29,113
+3,484
| +14% | +$125K |
|
6425
Kaiser Aluminum
KALU
$2.98B
| $1.12M | ﹤0.01% |
11,356
-51,214
| -82% | -$3.92M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.